CAS 83-73-8: 5,7-Diiodo-8-hydroxyquinoline

Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused

Diiodohydroxyquinoline

Applications Antiamebic. References Lawrence, S., et al.: J. Biol. Chem., 284, 35807 (2009), Gohil, V., et al.: Nat. Biotechnol., 28, 249 (2010),

Iodoquinol is a quinoline derivative that has been shown to have antifungal properties in vitro. It is used to treat bowel disease and infectious diseases, such as malaria and tuberculosis. Iodoquinol has also been shown to reduce the incidence of autoimmune diseases by inhibiting the production of pro-inflammatory cytokines. The mechanism of action for this drug is not well understood, but it is believed that it reacts with DNA and may inhibit the synthesis of proteins. It has also been shown to cause genotoxic effects in a model system by binding covalently to DNA, as well as benzalkonium chloride

Iodoquinol is a quinolone antibiotic that is used as an anti-infective agent. It has been approved by the FDA for the treatment of bacterial vaginosis, and it has also been shown to be effective against other conditions such as inflammatory diseases and autoimmune diseases. Iodoquinol has been shown to have genotoxic effects by binding to DNA in human cells and causing damage. This drug can act as a free radical scavenger and suppress inflammation, which may be due to its ability to inhibit fatty acid synthesis in the body.

DIIodohydroxyquinoline

Diiodohydroxyquinoline (Iodoquinol), a topical therapeutic agent, has satisfactory antibacterial properties.